Boule Diagnostics AB

📍 Spånga, Sweden👥 140 employees💰 Last funded May 2018
Boule Diagnostics develops and manufactures diagnostic instruments and consumables for healthcare providers worldwide. The company’s primary focus is in small to medium-sized hospitals, clinics, and laboratories in both human and veterinary diagnostics. Boule has a strong heritage when it comes to hematology diagnostics. Our blood tests help provide one of the first and most important indicators of a disease state and Boule systems play an increasingly role in helping build the infrastructure of healthcare for small and medium size patient care environments in both human and veterinary diagnostic markets. Boule operates via subsidiaries in Sweden, the USA, Mexico and Russia. The company products are sold globally primarily through more than 200 distributors and partners in more than 100 countries, supported by Boule’s own local sales and support personnel. The Boule shares are listed on Nasdaq Stockholm since 2011
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography1 country
Sweden
2
Investor activity2014–2018 · investors recorded per year
201412015120181
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Boule Diagnostics AB?
Boule Diagnostics AB has 3 investors on record on gritt.io.
When did Boule Diagnostics AB last raise funding?
The most recent investment in Boule Diagnostics AB recorded on gritt.io was in May 2018.
What industry is Boule Diagnostics AB in?
Boule Diagnostics AB operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is Boule Diagnostics AB based?
Boule Diagnostics AB is headquartered in Spånga, Sweden.